[Federal Register Volume 63, Number 196 (Friday, October 9, 1998)]
[Notices]
[Page 54482]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-27081]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


1998 FDA Science Forum on Biotechnology: Advances, Applications, 
and Regulatory Challenges

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

    The Food and Drug Administration's (FDA's) Office of Science is 
announcing the following meeting: ``1998 FDA Science Forum on 
Biotechnology: Advances, Applications, and Regulatory Challenges.'' The 
meeting will bring FDA scientists together with representatives of 
industry, academia, government agencies, consumer groups, and the 
public to discuss the impact of the enormous advances in biotechnology 
on product development and regulation. The program will encompass 
bioengineered products, novel therapeutic and preventive approaches, 
diagnostics and detection methodologies, and safety and efficacy 
assessment.

    Date and Time: The meeting will be held on December 8, 1998, 8:30 
a.m. to 6 p.m., and December 9, 1998, 8:30 a.m. to 5 p.m.

    Location: Washington Convention Center, rms. 30-33 (lower level) 
and Hall C (upper level), 900 Ninth St. NW., Washington, DC.

    Contact: Susan A. Homire, Office of Science (HF-33), Food and Drug 
Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-3366, 
e-mail ``[email protected]'' or American Association of 
Pharmaceutical Scientists 703-518-8429, e-mail ``[email protected]''.

    Registration: December 8 and 9, 1998, 7 a.m. to 8:30 a.m. 
Registration and program information are available on the Internet at 
``http://www.aaps.org/edumeet.html''. Attendance will be limited, 
therefore, interested parties are encouraged to register early.
    If you need special accommodations due to a disability, please 
contact the American Association of Pharmaceutical Scientists at least 
3 weeks in advance.


    Dated: October 1, 1998.
 William K. Hubbard,
 Associate Commissioner for Policy Coordination.
[FR Doc. 98-27081 Filed 10-8-98; 8:45 am]
BILLING CODE 4160-01-F